Yasmeen Mir

Liverpool, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Management of high-risk (B3) breast lesions in symptomatic practice: evidence review and practical recommendations for multidisciplinary care.

Management of high-risk (B3) breast lesions in symptomatic practice: evidence review and practical recommendations for multidisciplinary care.

Journal: Virchows Archiv : an international journal of pathology

Published: June 19, 2026

International Expert Consensus Recommendations for HER2 Reporting in Breast Cancer: Focus on HER2-Low and Ultralow Categories.

International Expert Consensus Recommendations for HER2 Reporting in Breast Cancer: Focus on HER2-Low and Ultralow Categories.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: July 07, 2025

Diagnostic interobserver variability of atypia assessment in columnar cell lesions among a group of expert breast pathologists in the United Kingdom and the Republic of Ireland, on behalf of the UK national coordinating committee for breast pathology.

Diagnostic interobserver variability of atypia assessment in columnar cell lesions among a group of expert breast pathologists in the United Kingdom and the Republic of Ireland, on behalf of the UK national coordinating committee for breast pathology.

Journal: Histopathology

Published: June 02, 2024

Pathological Changes Following Neoadjuvant Endocrine Therapy (NAET): A Multicentre Study of 391 Breast Cancers.

Pathological Changes Following Neoadjuvant Endocrine Therapy (NAET): A Multicentre Study of 391 Breast Cancers.

Journal: International journal of molecular sciences

Published: April 19, 2024

Morphological and molecular changes of oestrogen receptor-positive breast cancer following bridging endocrine therapy: a United Kingdom multicentre study.

Morphological and molecular changes of oestrogen receptor-positive breast cancer following bridging endocrine therapy: a United Kingdom multicentre study.

Journal: Histopathology

Published: January 15, 2024

Concordance of HER2-low scoring in breast carcinoma among expert pathologists in the United Kingdom and the republic of Ireland -on behalf of the UK national coordinating committee for breast pathology.

Concordance of HER2-low scoring in breast carcinoma among expert pathologists in the United Kingdom and the republic of Ireland -on behalf of the UK national coordinating committee for breast pathology.

Journal: Breast (Edinburgh, Scotland)

Published: April 26, 2023

Inter- and Intra-Observer Agreement of PD-L1 SP142 Scoring in Breast Carcinoma-A Large Multi-Institutional International Study.

Inter- and Intra-Observer Agreement of PD-L1 SP142 Scoring in Breast Carcinoma-A Large Multi-Institutional International Study.

Journal: Cancers

Published: November 01, 2022

MANAGEMENT OF MICROMETASTASIS FOUND ON SENTINEL LYMPH NODE BIOPSY USING OSNA IN PATIENTS DIAGNOSED WITH EARLY BREAST CANCER: IGCS-0021 Breast Cancer.

MANAGEMENT OF MICROMETASTASIS FOUND ON SENTINEL LYMPH NODE BIOPSY USING OSNA IN PATIENTS DIAGNOSED WITH EARLY BREAST CANCER: IGCS-0021 Breast Cancer.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: May 09, 2015

Showing 1-8 of 8

Last Updated: 09/26/2026